By Federico Pisani, Policy Assistant, EPHA Antimicrobial Resistance (AMR) continues to be a critical public health challenge with European and global impact. EPHA’s updated Position Paper on AMR, originally released in May 2017 explores the relevance and impact...
The MEP Interest Group on AMR organised a forward-looking discussion on the current state and prospects for the future of the antibiotic innovation pipeline as part of their series of webinars leading up to European Antibiotic Awareness Day. The discussion, hosted by...
The COVID-19 pandemic has shed light on the essential role that health plays in all aspects of our societies. Leading to new and old priorities being studied and tackled. Among the key priorities, a reinvigorated effort is being developed focusing on antimicrobial...
Guest article Jean-Yves Stenuick, Pharmaceuticals Policy & Projects Officer, Health Care Without Harm (HCWH) Europe The MEP Interest Group on AMR organised an online discussion on the environmental aspects of antimicrobial resistance on 13 November 2020 as part of...
Fixing the antibiotic innovation pipeline MEP Interest Group on AMR 17 November 2020 11:00 - 12:00 CET Online The third of three online discussions in the run-up to European Antibiotic Awareness Day hosted by the MEP Interest Group on AMR to raise awareness of...
